Trial intelligence / Profile preview

Feasibility of Outpatient Total Knee Arthroplasty: Role of Sciatic Nerve Block

2016-000226-19Phase 4Active

Sponsor
Association AERCOT
Start
Apr 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of ropivacaine in knee osteoarthritis (OA) and postoperative pain, sponsored by Association AERCOT. Primary endpoint: Ambulatory success rate up to postoperative day 5. Started Apr 2016; status: active.

02

Drugs

ropivacaine
03

Conditions

knee osteoarthritis (OA)postoperative pain

Beyond the preview

Go deeper on 2016-000226-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000226-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call